Clinical Trials Directory

Trials / Sponsors / Adrian Vella

Adrian Vella

Academic / Other · 9 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingThe Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction
Type2diabetes
Phase 22022-12-15
Active Not RecruitingThe Effects of Glucagon on Hepatic Metabolism
Obesity, Type2diabetes, NAFLD
Phase 1 / Phase 22022-10-20
CompletedA Study to Evaluate the Effect of Genetic Variation on Beta-cell Function During Fasting and Hyperglycemia in
Healthy
Phase 32022-10-17
CompletedEndogenous GLP-1 Secretion on Islet Function in People With and Without Type 2 Diabetes
Healthy, Type 2 Diabetes
Phase 32021-04-15
CompletedA Dose-response Study Examining the Contribution of GLP-1 Receptor Signaling to Glucagon-stimulated Insulin Se
Healthy
Phase 32021-03-04
CompletedThe Effect of the Interaction of Glucagon and Insulin on Endogenous Glucose Production in Humans
Healthy
Phase 32020-10-14
CompletedThe Contribution of Incretin Hormones to Post-prandial Glucose Metabolism After Roux-en-Y Gastric Bypass
Type 2 Diabetes Mellitus
EARLY_Phase 12012-03-01
CompletedThe Contribution of Incretin Hormones to the Amelioration of Glucose Metabolism After Roux-en-Y Gastric Bypass
Type 2 Diabetes Mellitus
EARLY_Phase 12011-06-01
CompletedDose-response Study of Exendin-9,39 on Glucose Metabolism
Pancreatic Effects of 9,39-Exendin and 9,36-GLP-1
Phase 12011-05-01